Path to profitability, page-3

Agreed RF current MC has factored in the previous deals with Fed Govt and the UK deal what we don’t know is what’s in the background. I think what will rerate the Co will be further international deals and the timelines of Fed Govt roll out out plus any other deals PD has managed to secure in Oz. Children’s APP trials should be finished this Q and trying to valuate the Co on that side of the business model will be hard once CE and TGA approval is granted because of the size of that market. Hopefully next Q will give us an update on FDA progress.